KRAS and cancer: Among human cancers induced by mutations of RAS proteins, KRAS is the most frequently mutated oncogene, mainly occurring at the residues G12 and G13 and accounting for respective mutation rates of 86–96% in pancreatic cancers [13], 40–54% in colorectal cancers [1], and 27–39% in lung adenocarcinomas [14].